Ghrelin and relamorelin alleviate hypoglycaemia in humanised mice with congenital hyperinsulinism
Lithovius, V.; Montaser, H.; Saarimäki-Vire, J.; Ibrahim, H.; Barsby, T.; Balboa, D.; Otonkoski, T.
Show abstract
KATP-channel related hyperinsulinism (KATPHI) is a genetic disorder of the pancreatic beta cells, manifesting as life-threatening hypoglycaemia in neonates due to dysregulated insulin secretion. Management of the severe diffuse form of KATPHI currently lacks treatment options, as the first-line therapy octreotide is often insufficiently effective, necessitating radical pancreatectomy in many patients. In this study, we applied stem cell derived islets carrying KATPHI-causing mutation KCNJ11-/- to develop new pharmaceutical therapies for KATPHI. We tested seven candidate molecules in vitro, identifying three that reduced insulin secretion in KCNJ11-/- stem cell derived islets. Of these, we tested acyl-ghrelin and its long-acting analogue relamorelin in mice that became hypoglycaemic due to carrying human KCNJ11-/- stem cell derived grafts. Acyl-ghrelin and relamorelin alone increased fasting glycaemia. Combining relamorelin with octreotide increased blood glucose more than the sum of each drug alone, reversing hypoglycaemia to normoglycaemia. In conclusion, we show that ghrelin receptor agonists have acute anti-hypoglycaemic effects in a humanised mouse model of KATPHI, especially when combined with octreotide. Relamorelin has been tested in >650 diabetic adults with little side effects, leading us to propose relamorelin - octreotide combination as a novel therapeutic candidate for severe KATPHI patients.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners 96%
- Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes 95%
- Permanent Neonatal diabetes-causing Insulin mutations have dominant negative effects on beta cell identity 93%
Similar papers in this journal
- β-cell SENP1 facilitates responsiveness to incretins and limits oral glucose intolerance in high fat fed mice 95%
- Glucose-dependent miR-125b is a negative regulator of β-cell function 95%
- Microvascular homeostasis is compromised in pancreatic islets in a mouse model of beta cell loss and low-grade inflammation 94%
Similar papers in this journal
- Proteomic predictors of individualized nutrient-specific insulin secretion in health and disease 95%
- Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation 93%
- Heterogenous impairment of α-cell function in type 2 diabetes is linked to cell maturation state 93%
Similar papers in this journal
- Generation and application of novel hES cell reporter lines for the differentiation and maturation of hPS cell-derived islet-like clusters 96%
- Pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans 96%
- Neuropeptide Neuromedin B does not alter body weight and glucose homeostasis nor does it act as an insulin-releasing peptide 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.